{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T03:01:03Z","timestamp":1775012463218,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T00:00:00Z","timestamp":1639958400000},"content-version":"vor","delay-in-days":19,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"national natural science foundation of china","doi-asserted-by":"publisher","award":["81670415"],"award-info":[{"award-number":["81670415"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nutr Metab (Lond)"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Hyperuricemia (HUA) has been proved as a predictor of worse outcomes in patients with coronary artery disease. Here, we investigated the prognostic value of HUA in a distinct population with myocardial infarction with nonobstructive coronary arteries (MINOCA).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A total of 1179 MINOCA patients were enrolled and divided into HUA and non-HUA groups. HUA was defined as a serum uric acid level\u2009\u2265\u2009420\u00a0\u03bcmol\/L in men or\u2009\u2265\u2009357\u00a0\u03bcmol\/L in women. The primary study endpoint was a composite of major adverse cardiovascular events (MACE), including all-cause death, nonfatal MI, nonfatal stroke, revascularization, and hospitalization for unstable angina or heart failure. Kaplan\u2013Meier, Cox regression, and receiver-operating characteristic analyses were performed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Patients with HUA (prevalence of 23.5%) had a significantly higher incidence of MACE (18.7% vs. 12.8%; <jats:italic>p<\/jats:italic>\u2009=\u20090.015) than patients without during the median follow-up of 41.7\u00a0months. HUA was closely associated with an increased risk of MACE even after multivariable adjustment (hazard ratio 1.498, 95% confidence interval: 1.080 to 2.077; <jats:italic>p<\/jats:italic>\u2009=\u20090.016). HUA remained a robust risk factor of MACE after propensity score matching analysis. Moreover, HUA showed an area under the curve (AUC) of 0.59 for predicting MACE. Incorporation of HUA to the thrombolysis in myocardial infarction (TIMI) score yielded a significant improvement in discrimination for MACE.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>HUA was independently associated with poor prognosis after MINOCA. Routine assessment of HUA may facilitate risk stratification in this specific population.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12986-021-00636-2","type":"journal-article","created":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T10:03:12Z","timestamp":1639994592000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Hyperuricemia as a prognostic marker for long-term outcomes in patients with myocardial infarction with nonobstructive coronary arteries"],"prefix":"10.1186","volume":"18","author":[{"given":"Wenjian","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Side","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sizhuang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiansong","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8704-6110","authenticated-orcid":false,"given":"Mengyue","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,12,20]]},"reference":[{"key":"636_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jacc.2017.04.052","volume":"70","author":"GA Roth","year":"2017","unstructured":"Roth GA, Johnson C, Abajobir A, Abd-Allah F, Abera SF, Abyu G, et al. Global, regional, and national burden of cardiovascular diseases for 10 Causes, 1990 to 2015. J Am Coll Cardiol. 2017;70:1\u201325. https:\/\/doi.org\/10.1016\/j.jacc.2017.04.052.","journal-title":"J Am Coll Cardiol"},{"key":"636_CR2","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/j.1365-2796.2012.02591.x","volume":"273","author":"JF Beltrame","year":"2013","unstructured":"Beltrame JF. Assessing patients with myocardial infarction and nonobstructed coronary arteries (MINOCA). J Int Med. 2013;273:182\u20135. https:\/\/doi.org\/10.1111\/j.1365-2796.2012.02591.x.","journal-title":"J Int Med"},{"key":"636_CR3","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1093\/eurheartj\/ehw149","volume":"38","author":"S Agewall","year":"2017","unstructured":"Agewall S, Beltrame JF, Reynolds HR, Niessner A, Rosano G, Caforio AL, et al. ESC working group position paper on myocardial infarction with non-obstructive coronary arteries. Eur Heart J. 2017;38:143\u201353. https:\/\/doi.org\/10.1093\/eurheartj\/ehw149.","journal-title":"Eur Heart J"},{"key":"636_CR4","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1161\/CIRCULATIONAHA.114.011201","volume":"131","author":"S Pasupathy","year":"2015","unstructured":"Pasupathy S, Air T, Dreyer RP, Tavella R, Beltrame JF. Systematic review of patients presenting with suspected myocardial infarction and nonobstructive coronary arteries. Circulation. 2015;131:861\u201370. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.114.011201.","journal-title":"Circulation"},{"key":"636_CR5","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1093\/eurheartj\/ehu469","volume":"36","author":"G Niccoli","year":"2015","unstructured":"Niccoli G, Scalone G, Crea F. Acute myocardial infarction with no obstructive coronary atherosclerosis: mechanisms and management. Eur Heart J. 2015;36:475\u201381. https:\/\/doi.org\/10.1093\/eurheartj\/ehu469.","journal-title":"Eur Heart J"},{"key":"636_CR6","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ijcard.2018.04.004","volume":"264","author":"KR Bainey","year":"2018","unstructured":"Bainey KR, Welsh RC, Alemayehu W, Westerhout CM, Traboulsi D, Anderson T, et al. Population-level incidence and outcomes of myocardial infarction with non-obstructive coronary arteries (MINOCA): insights from the Alberta contemporary acute coronary syndrome patients invasive treatment strategies (COAPT) study. Int J Cardiol. 2018;264:12\u20137. https:\/\/doi.org\/10.1016\/j.ijcard.2018.04.004.","journal-title":"Int J Cardiol"},{"key":"636_CR7","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1093\/eurheartj\/ehx491","volume":"39","author":"HB Andersson","year":"2018","unstructured":"Andersson HB, Pedersen F, Engstr\u00f8m T, Helqvist S, Jensen MK, J\u00f8rgensen E, et al. Long-term survival and causes of death in patients with ST-elevation acute coronary syndrome without obstructive coronary artery disease. Eur Heart J. 2018;39:102\u201310. https:\/\/doi.org\/10.1093\/eurheartj\/ehx491.","journal-title":"Eur Heart J"},{"key":"636_CR8","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1161\/CIRCINTERVENTIONS.113.000606","volume":"7","author":"D Planer","year":"2014","unstructured":"Planer D, Mehran R, Ohman EM, White HD, Newman JD, Xu K, et al. Prognosis of patients with non-ST-segment-elevation myocardial infarction and nonobstructive coronary artery disease: propensity-matched analysis from the Acute Catheterization and Urgent Intervention Triage Strategy trial. Circ Cardiovasc Interv. 2014;7:285\u201393. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.113.000606.","journal-title":"Circ Cardiovasc Interv"},{"key":"636_CR9","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ijcard.2019.02.036","volume":"287","author":"FA Abdu","year":"2019","unstructured":"Abdu FA, Liu L, Mohammed AQ, Luo Y, Xu S, Auckle R, et al. Myocardial infarction with non-obstructive coronary arteries (MINOCA) in Chinese patients: clinical features, treatment and 1 year follow-up. Int J Cardiol. 2019;287:27\u201331. https:\/\/doi.org\/10.1016\/j.ijcard.2019.02.036.","journal-title":"Int J Cardiol"},{"key":"636_CR10","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1136\/heartjnl-2012-302535","volume":"99","author":"M Kanbay","year":"2013","unstructured":"Kanbay M, Segal M, Afsar B, Kang DH, Rodriguez-Iturbe B, Johnson RJ. The role of uric acid in the pathogenesis of human cardiovascular disease. Heart. 2013;99:759\u201366. https:\/\/doi.org\/10.1136\/heartjnl-2012-302535.","journal-title":"Heart"},{"key":"636_CR11","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/sj.jhh.1002095","volume":"20","author":"A Shankar","year":"2006","unstructured":"Shankar A, Klein R, Klein BE, Nieto FJ. The association between serum uric acid level and long-term incidence of hypertension: population-based cohort study. J Hum Hypertens. 2006;20:937\u201345. https:\/\/doi.org\/10.1038\/sj.jhh.1002095.","journal-title":"J Hum Hypertens"},{"key":"636_CR12","doi-asserted-by":"publisher","first-page":"361","DOI":"10.2337\/dc07-1276","volume":"31","author":"A Dehghan","year":"2008","unstructured":"Dehghan A, van Hoek M, Sijbrands EJ, Hofman A, Witteman JC. High serum uric acid as a novel risk factor for type 2 diabetes. Diabetes Care. 2008;31:361\u20132. https:\/\/doi.org\/10.2337\/dc07-1276.","journal-title":"Diabetes Care"},{"key":"636_CR13","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1097\/HJH.0000000000000701","volume":"33","author":"C Borghi","year":"2015","unstructured":"Borghi C, Rosei EA, Bardin T, Dawson J, Dominiczak A, Kielstein JT, et al. Serum uric acid and the risk of cardiovascular and renal disease. J Hypertens. 2015;33:1729\u201341. https:\/\/doi.org\/10.1097\/HJH.0000000000000701.","journal-title":"J Hypertens"},{"key":"636_CR14","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1161\/01.HYP.0000091371.53502.D3","volume":"42","author":"K Masuo","year":"2003","unstructured":"Masuo K, Kawaguchi H, Mikami H, Ogihara T, Tuck ML. Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation. Hypertension. 2003;42:474\u201380. https:\/\/doi.org\/10.1161\/01.HYP.0000091371.53502.D3.","journal-title":"Hypertension"},{"key":"636_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-021-01849-4","author":"L Li","year":"2021","unstructured":"Li L, Zhao M, Wang C, Zhang S, Yun C, Chen S, et al. Early onset of hyperuricemia is associated with increased cardiovascular disease and mortality risk. Clin Res Cardiol. 2021. https:\/\/doi.org\/10.1007\/s00392-021-01849-4.","journal-title":"Clin Res Cardiol"},{"key":"636_CR16","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.amjcard.2018.12.016","volume":"123","author":"MI Ahmad","year":"2019","unstructured":"Ahmad MI, Dutta A, Anees MA, Soliman EZ. Interrelations between serum uric acid, silent myocardial infarction, and mortality in the general population. Am J Cardiol. 2019;123:882\u20138. https:\/\/doi.org\/10.1016\/j.amjcard.2018.12.016.","journal-title":"Am J Cardiol"},{"key":"636_CR17","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ijcard.2020.03.083","volume":"314","author":"X Tian","year":"2020","unstructured":"Tian X, Zuo Y, Chen S, Wang A, Li H, He Y, et al. Associations between changes in serum uric acid and the risk of myocardial infarction. Int J Cardiol. 2020;314:25\u201331. https:\/\/doi.org\/10.1016\/j.ijcard.2020.03.083.","journal-title":"Int J Cardiol"},{"key":"636_CR18","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.1681\/ASN.2014070660","volume":"26","author":"ME Kleber","year":"2015","unstructured":"Kleber ME, Delgado G, Grammer TB, Silbernagel G, Huang J, Kr\u00e4mer BK, et al. Uric acid and cardiovascular events: a mendelian randomization study. J Am Soc Nephrol. 2015;26:2831\u20138. https:\/\/doi.org\/10.1681\/ASN.2014070660.","journal-title":"J Am Soc Nephrol"},{"key":"636_CR19","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12872-016-0379-z","volume":"16","author":"T Zuo","year":"2016","unstructured":"Zuo T, Liu X, Jiang L, Mao S, Yin X, Guo L. Hyperuricemia and coronary heart disease mortality: a meta-analysis of prospective cohort studies. BMC Cardiovasc Disord. 2016;16:207. https:\/\/doi.org\/10.1186\/s12872-016-0379-z.","journal-title":"BMC Cardiovasc Disord"},{"key":"636_CR20","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1016\/j.metabol.2012.05.014","volume":"61","author":"G Ndrepepa","year":"2012","unstructured":"Ndrepepa G, Braun S, King L, Hadamitzky M, Haase HU, Birkmeier KA, et al. Association of uric acid with mortality in patients with stable coronary artery disease. Metabolism. 2012;61:1780\u20136. https:\/\/doi.org\/10.1016\/j.metabol.2012.05.014.","journal-title":"Metabolism"},{"key":"636_CR21","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.amjcard.2018.11.027","volume":"123","author":"C Zhang","year":"2019","unstructured":"Zhang C, Jiang L, Xu L, Tian J, Liu J, Zhao X, et al. Implications of hyperuricemia in severe coronary artery disease. Am J Cardiol. 2019;123:558\u201364. https:\/\/doi.org\/10.1016\/j.amjcard.2018.11.027.","journal-title":"Am J Cardiol"},{"key":"636_CR22","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ijcard.2017.04.027","volume":"240","author":"M Magnoni","year":"2017","unstructured":"Magnoni M, Berteotti M, Ceriotti F, Mallia V, Vergani V, Peretto G, et al. Serum uric acid on admission predicts in-hospital mortality in patients with acute coronary syndrome. Int J Cardiol. 2017;240:25\u20139. https:\/\/doi.org\/10.1016\/j.ijcard.2017.04.027.","journal-title":"Int J Cardiol"},{"key":"636_CR23","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.atherosclerosis.2018.01.017","volume":"269","author":"A Lopez-Pineda","year":"2018","unstructured":"Lopez-Pineda A, Cordero A, Carratala-Munuera C, Orozco-Beltran D, Quesada JA, Bertomeu-Gonzalez V, et al. Hyperuricemia as a prognostic factor after acute coronary syndrome. Atherosclerosis. 2018;269:229\u201335. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.01.017.","journal-title":"Atherosclerosis"},{"key":"636_CR24","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.atherosclerosis.2018.02.003","volume":"270","author":"M Tscharre","year":"2018","unstructured":"Tscharre M, Herman R, Rohla M, Hauser C, Farhan S, Freynhofer MK, et al. Uric acid is associated with long-term adverse cardiovascular outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Atherosclerosis. 2018;270:173\u20139. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.02.003.","journal-title":"Atherosclerosis"},{"key":"636_CR25","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.amjcard.2011.09.042","volume":"109","author":"MG Kaya","year":"2012","unstructured":"Kaya MG, Uyarel H, Akpek M, Kalay N, Ergelen M, Ayhan E, et al. Prognostic value of uric acid in patients with ST-elevated myocardial infarction undergoing primary coronary intervention. Am J Cardiol. 2012;109:486\u201391. https:\/\/doi.org\/10.1016\/j.amjcard.2011.09.042.","journal-title":"Am J Cardiol"},{"key":"636_CR26","doi-asserted-by":"publisher","first-page":"636","DOI":"10.21037\/atm.2019.10.110","volume":"7","author":"W Guo","year":"2019","unstructured":"Guo W, Yang D, Wu D, Liu H, Chen S, Liu J, et al. Hyperuricemia and long-term mortality in patients with acute myocardial infarction undergoing percutaneous coronary intervention. Ann Transl Med. 2019;7:636. https:\/\/doi.org\/10.21037\/atm.2019.10.110.","journal-title":"Ann Transl Med"},{"key":"636_CR27","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1016\/j.numecd.2021.01.023","volume":"31","author":"A Maloberti","year":"2021","unstructured":"Maloberti A, Bossi I, Tassistro E, Rebora P, Racioppi A, Nava S, et al. Uric acid in chronic coronary syndromes: Relationship with coronary artery disease severity and left ventricular diastolic parameter. Nutr Metab Cardiovasc Dis. 2021;31:1501\u20138. https:\/\/doi.org\/10.1016\/j.numecd.2021.01.023.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"636_CR28","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.012738","volume":"8","author":"A Efstathiadou","year":"2019","unstructured":"Efstathiadou A, Gill D, McGrane F, Quinn T, Dawson J. Genetically determined uric acid and the risk of cardiovascular and neurovascular diseases: a Mendelian randomization study of outcomes investigated in randomized trials. J Am Heart Assoc. 2019;8: e012738. https:\/\/doi.org\/10.1161\/JAHA.119.012738.","journal-title":"J Am Heart Assoc"},{"key":"636_CR29","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","volume":"72","author":"K Thygesen","year":"2018","unstructured":"Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al. Fourth universal definition of myocardial infarction. J Am Coll Cardiol. 2018;72:2231\u201364. https:\/\/doi.org\/10.1016\/j.jacc.2018.08.1038.","journal-title":"J Am Coll Cardiol"},{"key":"636_CR30","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","volume":"37","author":"M Roffi","year":"2016","unstructured":"Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European society of cardiology (ESC). Eur Heart J. 2016;37:267\u2013315. https:\/\/doi.org\/10.1093\/eurheartj\/ehv320.","journal-title":"Eur Heart J"},{"key":"636_CR31","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","volume":"39","author":"B Ibanez","year":"2018","unstructured":"Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39:119\u201377. https:\/\/doi.org\/10.1093\/eurheartj\/ehx393.","journal-title":"Eur Heart J"},{"key":"636_CR32","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1001\/jama.284.7.835","volume":"284","author":"EM Antman","year":"2000","unstructured":"Antman EM, Cohen M, Bernink PJ, McCabe CH, Horacek T, Papuchis G, et al. The TIMI risk score for unstable angina\/non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA. 2000;284:835\u201342. https:\/\/doi.org\/10.1001\/jama.284.7.835.","journal-title":"JAMA"},{"key":"636_CR33","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1161\/01.cir.102.17.2031","volume":"102","author":"DA Morrow","year":"2000","unstructured":"Morrow DA, Antman EM, Charlesworth A, Cairns R, Murphy SA, de Lemos JA, et al. TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation: an intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation. 2000;102:2031\u20137. https:\/\/doi.org\/10.1161\/01.cir.102.17.2031.","journal-title":"Circulation"},{"key":"636_CR34","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.jacc.2017.12.048","volume":"71","author":"KA Hicks","year":"2018","unstructured":"Hicks KA, Mahaffey KW, Mehran R, Nissen SE, Wiviott SD, Dunn B, et al. 2017 Cardiovascular and stroke endpoint definitions for clinical trials. J Am Coll Cardiol. 2018;71:1021\u201334. https:\/\/doi.org\/10.1016\/j.jacc.2017.12.048.","journal-title":"J Am Coll Cardiol"},{"key":"636_CR35","doi-asserted-by":"publisher","first-page":"3449","DOI":"10.1002\/sim.5777","volume":"32","author":"H Ma","year":"2013","unstructured":"Ma H, Bandos AI, Rockette HE, Gur D. On use of partial area under the ROC curve for evaluation of diagnostic performance. Stat Med. 2013;32:3449\u201358. https:\/\/doi.org\/10.1002\/sim.5777.","journal-title":"Stat Med"},{"key":"636_CR36","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2307\/2531595","volume":"44","author":"ER Delong","year":"1988","unstructured":"Delong ER, Delong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a non-parametric approach. Biometrics. 1988;44:837\u201345.","journal-title":"Biometrics"},{"key":"636_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.716840","volume":"8","author":"AQ Mohammed","year":"2021","unstructured":"Mohammed AQ, Abdu FA, Liu L, Zhang W, Yin G, Xu Y, et al. Hyperuricemia predicts adverse outcomes after myocardial infarction with non-obstructive coronary arteries. Front Med (Lausanne). 2021;8: 716840. https:\/\/doi.org\/10.3389\/fmed.2021.716840.","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"636_CR38","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/eurjhf\/hft132","volume":"16","author":"H Huang","year":"2014","unstructured":"Huang H, Huang B, Li Y, Huang Y, Li J, Yao H, et al. Uric acid and risk of heart failure: a systematic review and meta-analysis. Eur J Heart Fail. 2014;16(1):15\u201324. https:\/\/doi.org\/10.1093\/eurjhf\/hft132.","journal-title":"Eur J Heart Fail"},{"key":"636_CR39","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ijcard.2015.08.086","volume":"213","author":"S Biscaglia","year":"2016","unstructured":"Biscaglia S, Ceconi C, Malagu M, Pavasini R, Ferrari R. Uric acid and coronary artery disease: an elusive link deserving further attention. Int J Cardiol. 2016;213:28\u201332. https:\/\/doi.org\/10.1016\/j.ijcard.2015.08.086.","journal-title":"Int J Cardiol"},{"key":"636_CR40","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1093\/eurheartj\/ehi879","volume":"27","author":"C Ruggiero","year":"2006","unstructured":"Ruggiero C, Cherubini A, Ble A, Bos AJ, Maggio M, Dixit VD, et al. Uric acid and inflammatory markers. Eur Heart J. 2006;27:1174\u201381. https:\/\/doi.org\/10.1093\/eurheartj\/ehi879.","journal-title":"Eur Heart J"},{"key":"636_CR41","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1161\/HYPERTENSIONAHA.116.08436","volume":"69","author":"M Prasad","year":"2017","unstructured":"Prasad M, Matteson EL, Herrmann J, Gulati R, Rihal CS, Lerman LO, et al. Uric acid is associated with inflammation, coronary microvascular dysfunction, and adverse outcomes in postmenopausal women. Hypertension. 2017;69:236\u201342. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.116.08436.","journal-title":"Hypertension"},{"key":"636_CR42","doi-asserted-by":"publisher","first-page":"13334","DOI":"10.1096\/fj.201901148R","volume":"33","author":"J Ko","year":"2019","unstructured":"Ko J, Kang HJ, Kim DA, Kim MJ, Ryu ES, Lee S, et al. Uric acid induced the phenotype transition of vascular endothelial cells via induction of oxidative stress and glycocalyx shedding. FASEB J. 2019;33:13334\u201345. https:\/\/doi.org\/10.1096\/fj.201901148R.","journal-title":"FASEB J"},{"key":"636_CR43","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.jhep.2015.11.022","volume":"64","author":"X Wan","year":"2016","unstructured":"Wan X, Xu C, Lin Y, Lu C, Li D, Sang J, et al. Uric acid regulates hepatic steatosis and insulin resistance through the NLRP3 inflammasome-dependent mechanism. J Hepatol. 2016;64:925\u201332. https:\/\/doi.org\/10.1016\/j.jhep.2015.11.022.","journal-title":"J Hepatol"},{"key":"636_CR44","doi-asserted-by":"publisher","first-page":"4642","DOI":"10.1038\/ncomms5642","volume":"5","author":"BJ DeBosch","year":"2014","unstructured":"DeBosch BJ, Kluth O, Fujiwara H, Schurmann A, Moley K. Earlyonset metabolic syndrome in mice lacking the intestinal uric acid transporter SLC2A9. Nat Commun. 2014;5:4642. https:\/\/doi.org\/10.1038\/ncomms5642.","journal-title":"Nat Commun"}],"container-title":["Nutrition &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12986-021-00636-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12986-021-00636-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12986-021-00636-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T10:39:10Z","timestamp":1639996750000},"score":1,"resource":{"primary":{"URL":"https:\/\/nutritionandmetabolism.biomedcentral.com\/articles\/10.1186\/s12986-021-00636-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["636"],"URL":"https:\/\/doi.org\/10.1186\/s12986-021-00636-2","relation":{},"ISSN":["1743-7075"],"issn-type":[{"value":"1743-7075","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"16 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all participants. All work was approved by the Ethics Committee of Fuwai hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"107"}}